Rising Prevalence Of Cancer And Other Target Diseases To Drive Market Growth: Strategic Insights Driving Cell & Gene Therapy Manufacturing Services Market Momentum in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Cell & Gene Therapy Manufacturing Services Market Size By 2025?
Recent years have witnessed substantial expansion within the market for cell & gene therapy manufacturing services, projected to expand from a value of $8.15 billion in 2024 up to $9.44 billion by the year 2025, reflecting a compound annual growth rate (CAGR) engagement of 15.9%. This upward trajectory observed during the past period stems from a combination of factors, including augmented spending on research and development, supportive regulatory environments and established guidelines, an enlarging portfolio of available cell and gene therapies, greater industry cooperation and alliances being formed, and a rising worldwide need for patient-specific medical treatments.

How Big Is the Cell & Gene Therapy Manufacturing Services Market Size Expected to Grow by 2029?
Anticipated to experience swift expansion, the market encompassing cell and gene therapy manufacturing services is projected to reach a valuation of $17.92 billion by 2029, demonstrating a constant annual growth trajectory of 17.4%. This upward trend throughout the projected timeframe stems from factors such as the maturation and commercial viability of the market, a worldwide broadening of biopharmaceutical production capabilities, a greater tendency among pharmaceutical entities to outsource operations, progress in automated and robotic systems, and the arrival of novel treatment approaches. Key developments shaping this period involve escalating requirements for energy conservation, the adoption of cutting-edge materials and sophisticated technologies, the preference for smaller, adaptable unit designs, the shift towards electric modes of transit, and an intensified concentration on ensuring both security and dependable performance.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-manufacturing-services-global-market-report

Which Key Market Drivers Powering Cell & Gene Therapy Manufacturing Services Market Expansion and Growth?
Advancements in cell and gene therapy manufacturing services are anticipated to accelerate market expansion, predominantly fueled by the escalating prevalence of cancer and various other ailments targeted by these treatments. Cancer, characterized by the rapid and uncontrolled multiplication of aberrant bodily cells leading to malignant proliferation, is a significant health challenge. As these cellular and genetic manipulation methods emerge as compelling new avenues for confronting the increasing rates of cancer, there is a corresponding surge in the need for innovative and effective therapeutic modalities. To illustrate this trend, data from the American Cancer Society, a non-profit advocacy entity based in the US, indicated a rise in cancer diagnoses from 1,898,160 cases in 2021 to 1,958,310 cases in 2023, signifying a 3.16% upturn; consequently, this heightened occurrence of cancer, alongside other pertinent diseases, is projected to spur the forward momentum of the market for cell and gene therapy production support.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10035&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Cell & Gene Therapy Manufacturing Services Market?
A significant driver within the cell and gene therapy manufacturing services sector is the accelerating pace of technological innovation being embraced by key industry players seeking to maintain competitive advantage. Illustratively, in October 2022, US-based Charles River Laboratories International Inc., a provider of diverse preclinical, clinical laboratory, gene therapy, and cell therapy solutions, unveiled its navigation Vector Platform. This proprietary system is engineered to streamline the journey toward Good Manufacturing Practice (GMP) Adeno-Associated Virus (AAV) vector production, largely negating the need for exhaustive process refinement typically required; furthermore, researchers utilizing this navigation platform for viral vector gene therapy programs stand to achieve a reduction of up to 55 percent in the time needed to reach GMP status when contrasted with conventional production schedules. The foundation of Charles River's navigation methodology rests upon an exceptionally high-yielding HEK293 suspension cell line, which possesses scalability and serotyping flexibility tailored precisely to client specifications.

What Are the Emerging Segments in the Cell & Gene Therapy Manufacturing Services Market?
The cell & gene therapy manufacturing servicesmarket covered in this report is segmented -

1) By Type: Gene Therapy; Cell Therapy
2) By Indication: Central Nervous System Disorders; Ophthalmology Diseases; Cardiovascular Diseases; Infectious Diseases; Orthopedic Diseases; Oncology Diseases
3) By Application: Commercial Manufacturing; Clinical Manufacturing
4) By End-user: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Other End-Users

Subsegments:
1) By Gene Therapy: Viral Vector Manufacturing; Plasmid DNA Production; Gene Editing Services; Formulation And Fill-Finish Services
2) By Cell Therapy: Cell Sourcing And Banking; Cell Processing And Expansion; Quality Control And Testing Services; Cryopreservation And Storage Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10035&type=smp

Who Are the Global Leaders in the Cell & Gene Therapy Manufacturing Services Market?
Major companies operating in the cell & gene therapy manufacturing services market include Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories International Inc., Lonza Group AG, Catalent Inc., WuXi AppTec, Takara Bio Inc., Nikon Corporation, Fujifilm Holdings Corporation, F. Hoffmann-La Roche Ltd, Oxford Biomedica plc, CGT Catapult, bluebird bio Inc., Boehringer Ingelheim International GmbH, Innovative Cellular Therapeutics Co. Ltd., Samsung Biologics Co. Ltd., Novartis International AG, Pfizer Inc., Brammer Bio, AGC Biologics, Cognate BioServices Inc., Paragon Bioservices Inc., Merck KGaA operating as MilliporeSigma, Sarepta Therapeutics Inc., Spark Therapeutics Inc., Orchard Therapeutics plc, Precision BioSciences Inc., PCT a Hitachi Group Company, Aldevron LLC, BioNTech SE

Which are the Top Profitable Regional Markets for the Cell & Gene Therapy Manufacturing Services Industry?
North America was the largest region in the cell and gene therapy manufacturing services market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global cell & gene therapy manufacturing services market report forecast period. The regions covered in the cell & gene therapy manufacturing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10035

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.